IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
spe cial solid forms 13%
tab lets 8%
ESTONIA
NOVARTIS
Full Name: Novartis Pharma Ser vices AG
Street Ad dress: Peterburi tee 47, 11415 Tallinn
Tel: +372 6 062400
Fax: +372 6 062409
De scrip tion: Rep re sen ta tive of fice. Pro moter,
sales/detailer. Prod uct ranges in clude: phar ma -
ceu ti cal prod ucts (branded, pre scrip tion), hos pi tal
pharmaceuticals, oph thal mic prod ucts. Es tab -
lished 1996. 18 phar ma ceu ti cal em ploy ees in
2007. Di vi sions in clude: Novartis Con sumer
Health. General Medicines; Oncology.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 1-10 (2007)
Con tacts (Pharm): Chair man: Roland Lepik
Phar ma ceu ti cal Sales: US$ 6-7 mil lion
Prod ucts (% of Sales by Lead ing 5): 75-80%
Ther a peu tic Classes (% of Sales by Lead ing
5): 75-80%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
SANDIMMUN NEORAL (immunosuppressive
agent)
FEMARA (cytostatic hor mone an tag o nist)
LEPONEX (antipsychotic)
GLIVEC (antineoplastic other)
FORADIL (B2-stim u lant)
Ther a peu tic Range:
immunosuppressive agents 32%
cytostatic hor mone ther apy 15%
psycholeptics 12%
antineoplastics 11%
antiasthma and COPD prod ucts 9%
Lead ing Dose Forms:
cap sules 52%
tab lets 42%
coated tab lets 3%
creams 2%
am poules 1%
SANDOZ
Full Name: Sandoz Pharmaceuticals d.d.
Street Ad dress: Parnustr. 105, 11312 Tallinn
Tel: +372 6 652400
Fax: +372 6 652410
Home Page: www.sandoz.ee
De scrip tion: Rep re sen ta tive of fice. Pro moter.
Prod uct ranges in clude: phar ma ceu ti cal prod ucts
(pre scrip tion, non-pre scrip tion), herbal prod ucts.
Es tab lished 2002. 14 phar ma ceu ti cal employees
in 2007.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 11-20 (2007)
Con tacts (Pharm): Chair man: Agre Jarvelaid;
Com mer cial Op er a tions: Tiiu Kalmet; Gen eral
Con tact: Viivian Taal
Phar ma ceu ti cal Sales: US$ 6-7 mil lion
Prod ucts (% of Sales by Lead ing 5): 45-50%
Ther a peu tic Classes (% of Sales by Lead ing
5): 60-65%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
RAMICOR (ACE in hib i tor plain)
DICLAC (antirheumatic top i cal; antirheumatic
non-steroidal)
AMLOCARD (cal cium an tag o nist plain)
CO-RAMICOR (ACE in hib i tor com bi na tion)
ACC (ex pec to rant)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 25%
cal cium an tag o nists 11%
lipid-reg u lat ing/antiatheroma prep a ra tions
10%
cough and cold prep a ra tions 8%
beta-block ing agents 7%
Lead ing Dose Forms:
tab lets 73%
coated tab lets 9%
gels/sols 7%
cap sules 6%
pow ders/gran ules 4%
FINLAND
CIBA VI SION
Full Name: CIBA Vi sion Fin land Oy
Street Ad dress: Metsanneidonkuja 10,
FIN-02130 Espoo
Tel: +358 9 20340004
Fax: +358 9 20340010
Home Page: www.cibavision.fi
HEXAL
Full Name: Oy Hexal AB
Street Ad dress: Rajatorpantie 41C, FIN-01640
Vantaa
Tel: +358 9 8520 2030
© 2009 IMS Health In cor po rated or its af fil i ates Page 166